Literature DB >> 16935723

Comparison of the performance of tracer kinetic model-driven registration for dynamic contrast enhanced MRI using different models of contrast enhancement.

Giovanni A Buonaccorsi1, Caleb Roberts, Sue Cheung, Yvonne Watson, James P B O'Connor, Karen Davies, Alan Jackson, Gordon C Jayson, Geoff J M Parker.   

Abstract

RATIONALE AND
OBJECTIVES: The quantitative analysis of dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) data is subject to model fitting errors caused by motion during the time-series data acquisition. However, the time-varying features that occur as a result of contrast enhancement can confound motion correction techniques based on conventional registration similarity measures. We have therefore developed a heuristic, locally controlled tracer kinetic model-driven registration procedure, in which the model accounts for contrast enhancement, and applied it to the registration of abdominal DCE-MRI data at high temporal resolution.
MATERIALS AND METHODS: Using severely motion-corrupted data sets that had been excluded from analysis in a clinical trial of an antiangiogenic agent, we compared the results obtained when using different models to drive the tracer kinetic model-driven registration with those obtained when using a conventional registration against the time series mean image volume.
RESULTS: Using tracer kinetic model-driven registration, it was possible to improve model fitting by reducing the sum of squared errors but the improvement was only realized when using a model that adequately described the features of the time series data. The registration against the time series mean significantly distorted the time series data, as did tracer kinetic model-driven registration using a simpler model of contrast enhancement.
CONCLUSION: When an appropriate model is used, tracer kinetic model-driven registration influences motion-corrupted model fit parameter estimates and provides significant improvements in localization in three-dimensional parameter maps. This has positive implications for the use of quantitative DCE-MRI for example in clinical trials of antiangiogenic or antivascular agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935723     DOI: 10.1016/j.acra.2006.05.016

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  7 in total

1.  Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer.

Authors:  Huaijun Wang; Guy Marchal; Yicheng Ni
Journal:  World J Radiol       Date:  2011-01-28

2.  Implementation of a semi-automated post-processing system for parametric MRI mapping of human breast cancer.

Authors:  Robert E Lee; E Brian Welch; Jared G Cobb; Tuhin Sinha; John C Gore; Thomas E Yankeelov
Journal:  J Digit Imaging       Date:  2008-04-30       Impact factor: 4.056

3.  DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6.

Authors:  J P B O'Connor; C J Rose; A Jackson; Y Watson; S Cheung; F Maders; B J Whitcher; C Roberts; G A Buonaccorsi; G Thompson; A R Clamp; G C Jayson; G J M Parker
Journal:  Br J Cancer       Date:  2011-06-14       Impact factor: 7.640

Review 4.  DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents.

Authors:  J P B O'Connor; A Jackson; G J M Parker; G C Jayson
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

5.  An Overdetermined System of Transform Equations in Support of Robust DCE-MRI Registration With Outlier Rejection.

Authors:  Adam Johansson; James Balter; Mary Feng; Yue Cao
Journal:  Tomography       Date:  2016-09

Review 6.  Image registration in dynamic renal MRI-current status and prospects.

Authors:  Frank G Zöllner; Amira Šerifović-Trbalić; Gordian Kabelitz; Marek Kociński; Andrzej Materka; Peter Rogelj
Journal:  MAGMA       Date:  2019-10-09       Impact factor: 2.310

7.  Motion correction of free-breathing magnetic resonance renography using model-driven registration.

Authors:  Dimitra Flouri; Daniel Lesnic; Constantina Chrysochou; Jehill Parikh; Peter Thelwall; Neil Sheerin; Philip A Kalra; David L Buckley; Steven P Sourbron
Journal:  MAGMA       Date:  2021-06-23       Impact factor: 2.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.